journal article·2019-01-22

Hypoxia-Triggered Transforming Immunomodulator for Cancer Immunotherapy via Photodynamically Enhanced Antigen Presentation of Dendritic Cell

Sooseok Im, Junseok Lee, Dongsik Park, Areum Park, You-Me Kim, Won Jong Kim

ACS Nano· Volume 13· Issue 1
Publisher page

Abstract

A key factor for successful cancer immunotherapy (CIT) is the extent of antigen presentation by dendritic cells (DCs) that phagocytize tumor-associated antigens (TAA) in the tumor site and migrate to tumor draining lymph nodes (TDLN) for the activation of T cells. Although various types of adjuvant delivery have been studied to enhance the activity of the DCs, poor delivery efficiency and depleted population of tumor infiltrating DCs have limited the efficacy of CIT. Herein, we report a hypoxia-responsive mesoporous silica nanocarrier (denoted as CAGE) for an enhanced CIT assisted by photodynamic therapy (PDT). In this study, CAGE was designed as a hypoxia-responsive transforming carrier to improve the intracellular uptake of nanocarriers and the delivery of adjuvants to DCs. Furthermore, PDT was exploited for the generation of immunogenic debris and recruitment of DCs in a tumor site, followed by enhanced antigen presentation. Finally, a significant inhibition of tumor growth was observed in vivo, signifying that the PDT would be a promising solution for DC-based immunotherapy.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Immunotherapy and Immune Responses · Cancer Research and Treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Interdisciplinary Bioscience and Bioengineering, Pohang University of Science and Technology (POSTECH), Jigok-ro 64, Nam-gu, Pohang 37666, Republic of Korea

Department of Chemistry, Pohang University of Science and Technology (POSTECH), Cheongam-ro 77, Nam-gu, Pohang 37673, Republic of Korea

Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology (POSTECH), Jigok-ro 64, Nam-gu, Pohang 37666, Republic of Korea

Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, 291 Daehak-ro, Yuseong-gu, Daejeon 34141, Republic of Korea

Funding

National Research Foundation of Korea

References (64)

Show source-provided references
1. 10.1038/nrd350010.1038/nrd3500 ↗
2. 10.1038/nature1067310.1038/nature10673 ↗
3. 10.1038/3258810.1038/32588 ↗
4. 10.1016/j.it.2016.09.00610.1016/j.it.2016.09.006 ↗
5. 10.1038/nrc325810.1038/nrc3258 ↗
6. 10.1038/nm.331710.1038/nm.3317 ↗
7. 10.1371/journal.pone.010789410.1371/journal.pone.0107894 ↗
8. 10.1038/nnano.2017.11310.1038/nnano.2017.113 ↗
9. 10.1021/nn500211210.1021/nn5002112 ↗
10. 10.1038/ncomms1319310.1038/ncomms13193 ↗
11. 10.1016/j.addr.2008.08.00310.1016/j.addr.2008.08.003 ↗
12. 10.3322/caac.2011410.3322/caac.20114 ↗
13. 10.1038/nrc189410.1038/nrc1894 ↗
14. 10.1073/pnas.091435110710.1073/pnas.0914351107 ↗
15. 10.1038/nri178510.1038/nri1785 ↗
16. 10.4049/jimmunol.175.1.48710.4049/jimmunol.175.1.487 ↗
17. 10.1038/nri132910.1038/nri1329 ↗
18. 10.1016/j.addr.2008.12.00810.1016/j.addr.2008.12.008 ↗
19. 10.4049/jimmunol.165.12.688910.4049/jimmunol.165.12.6889 ↗
20. 10.1111/j.1365-2567.2007.02530.x10.1111/j.1365-2567.2007.02530.x ↗
21. 10.1016/S1471-4906(03)00243-610.1016/S1471-4906(03)00243-6 ↗
22. 10.3389/fimmu.2017.0004710.3389/fimmu.2017.00047 ↗
23. 10.4049/jimmunol.170.6.305910.4049/jimmunol.170.6.3059 ↗
24. 10.1038/ncomms287410.1038/ncomms2874 ↗
25. 10.1158/1078-0432.CCR-11-293810.1158/1078-0432.CCR-11-2938 ↗
26. 10.3390/vaccines303066210.3390/vaccines3030662 ↗
27. 10.1021/nn506202910.1021/nn5062029 ↗
28. 10.1016/S1359-6446(05)03575-010.1016/S1359-6446(05)03575-0 ↗
29. 10.1002/adma.20160662810.1002/adma.201606628 ↗
30. 10.1016/S0168-3659(03)00232-310.1016/S0168-3659(03)00232-3 ↗
31. 10.1039/c3tb21241f10.1039/c3tb21241f ↗
32. 10.1016/j.jconrel.2008.05.00910.1016/j.jconrel.2008.05.009 ↗
33. 10.1021/acs.bioconjchem.7b0033010.1021/acs.bioconjchem.7b00330 ↗
34. 10.1002/anie.20130836810.1002/anie.201308368 ↗
35. 10.1186/1741-7015-8-4510.1186/1741-7015-8-45 ↗
36. 10.1259/bjr.2013067610.1259/bjr.20130676 ↗
37. 10.1021/acsnano.6b0752510.1021/acsnano.6b07525 ↗
38. 10.1039/C7NR07677K10.1039/C7NR07677K ↗
39. 10.1002/anie.20150047810.1002/anie.201500478 ↗
40. 10.1002/adma.20150586910.1002/adma.201505869 ↗
41. 10.1097/01243894-200606000-0001810.1097/01243894-200606000-00018 ↗
42. 10.1177/15330346050040030810.1177/153303460500400308 ↗
43. 10.3390/ma603081710.3390/ma6030817 ↗
44. 10.1021/ja105937q10.1021/ja105937q ↗
45. 10.1021/acs.bioconjchem.6b0024110.1021/acs.bioconjchem.6b00241 ↗
46. 10.1021/acs.biomac.6b0035010.1021/acs.biomac.6b00350 ↗
47. 10.1039/C4RA14875D10.1039/C4RA14875D ↗
48. 10.1039/c2cc38510d10.1039/c2cc38510d ↗
49. 10.1021/ja064594310.1021/ja0645943 ↗
50. 10.7150/ntno.1857610.7150/ntno.18576 ↗
51. 10.1007/s12274-014-0558-010.1007/s12274-014-0558-0 ↗
52. 10.1080/1542140080224014410.1080/15421400802240144 ↗
53. 10.1021/ma60062a01410.1021/ma60062a014 ↗
54. 10.3390/molecules1510749810.3390/molecules15107498 ↗
55. 10.1039/C4RA15107K10.1039/C4RA15107K ↗
56. 10.1039/C6RA04077B10.1039/C6RA04077B ↗
57. 10.1021/acs.biomac.8b0029010.1021/acs.biomac.8b00290 ↗
58. 10.1038/srep0980610.1038/srep09806 ↗
59. 10.1186/1556-276X-9-36310.1186/1556-276X-9-363 ↗
60. Hafner M. · Cancer. Res. · 2001 · 61 · 5523
61. 10.1002/btm2.1000510.1002/btm2.10005 ↗
62. 10.1038/nbt.333010.1038/nbt.3330 ↗
63. 10.1002/wnan.136210.1002/wnan.1362 ↗
64. 10.1021/nn301159a10.1021/nn301159a ↗